Stock·NYSE·Financial Services
ICICI Bank Ltd. Sponsored (IBN)
- Market cap
- $107.66B
- P/E
- 16.73
- Dividend yield
- 0.00%
- Street target
- $36.50median of 4 analysts
- 52-week range
- $25.08 $31.85
The short version
Where IBN stands today, in four lines, and what CleaRank Financial AI makes of it.
IBN at a glance
ICICI Bank Ltd. Sponsored (IBN): Buy, 79/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($28.98 and $28.58).
- Earnings IBN beat estimates in 6 of its last 6 quarters, yet fell the next day after 1 of those beats.
- Valuation P/E of 16.7 against 16.5 for the Financial Services sector: broadly in line with peers (+1%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates ICICI Bank Ltd. Sponsored (IBN) Buy, with a model score of 79/100.
The analysts' outlook lifts the score most: 4 of 4 analysts rate it a buy and the median target is 21.7% above the price. The trend is up: IBN trades 3.49% above its 50-day average of $28.98 and 4.95% above its 200-day average of $28.58. Over the past year the price fell 5.93%.
Only on CleaRank
Figures we compute ourselves from IBN's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $29.99 is 3.5% above the 50-day simple moving average of $28.98.Price above its 200-day average ›
The price is 4.9% above the 200-day simple moving average of $28.58.50-day average above the 200-day ›
The 50-day average ($28.98) is 1.4% above the 200-day average ($28.58), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 73% of its 52-week range, between $25.08 and $31.85.
IBN share price
Pick a period: each tab shows how far IBN has moved over it, to the last close.
Today's trading
Where IBN sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 16.73 is 1.4% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 5.03 is 32.3% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $5.9B on revenue of $21.4B, a net margin of 27.5%.Beat estimates in most recent reports ›
IBN beat the EPS estimate in 6 of its last 6 reports.
Key statistics
The headline figures for IBN.
As of October 17, 2026, IBN trades at $29.99, with a market value of $107.66B and a P/E ratio of 16.73.
What the numbers say
CleaRank Financial AI's reading of IBN's valuation, growth and risks.
The trailing P/E of 16.73 for ICICI Bank Ltd. Sponsored (IBN) is 1.4% above the Financial Services median of 16.5, and the peer comparison on this page rates the P/E as broadly in line with peers. Measured against sales, the P/S of 5.03 is 32.4% above the sector median of 3.8.
Revenue grew 11.40% in the latest year, which is 0.3 percentage points slower than the sector median of 11.7%. On profitability, the net margin is 27.53% and the operating margin is 38.51%. Return on equity is 16.07%, above the sector median of 13.8%. Finally, debt-to-equity sits at 0.00.
IBN's July 18, 2026 report topped expectations by 2.44%, with EPS of $0.42 compared with an estimate of $0.41. In the first session after the report, the share price climbed 0.97%.
The record is a clean sweep: 6 beats in 6 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Analysts' average EPS estimate for this fiscal year is $1.61, which would be growth of 7.7%, and $1.87 for next year (growth of 16.2%).
Day to day, IBN's price typically moves 1.42%, based on the 30-day standard deviation of its daily returns.
IBN against the Financial Services sector
How IBN compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (1% difference), suggesting fair market pricing relative to industry standards.
Return vs XLF: Since May 6, 2025, IBN has lost 11.4% against a gain of 12.5% for XLF.
Performance against XLF
IBN and the Financial Services sector fund over the same days.
Revenue and earnings
How much IBN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.6% in FY2026 to ₹2.23T, from ₹1.82T a year earlier.
Profit margin: The net margin was 25.9% in FY2026, down from 30.0% the year before.
Profitable: IBN earned ₹579B in FY2026.
Earnings reality check
Did IBN beat what analysts expected, and how did the stock react?
Earnings record: IBN beat the analyst estimate in 6 of the last 6 quarters.
Market reaction: The stock fell in the first session after 1 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 18, 2026after close | $0.41 | $0.42 | +2.44% | +0.97% | +0.44% |
| Oct 18, 2025after close | $0.36 | $0.39 | +8.33% | +0.77% | +0.42% |
| Jul 19, 2025after close | $0.39 | $0.41 | +5.13% | -0.38% | -1.11% |
| Apr 19, 2025after close | $0.37 | $0.41 | +10.81% | +1.64% | -0.03% |
| Jan 25, 2025after close | $0.35 | $0.38 | +8.57% | +1.83% | +1.66% |
| Oct 26, 2024after close | $0.35 | $0.39 | +11.43% | +0.32% | -3.08% |
As of October 17, 2026, IBN has beaten the analyst EPS estimate in 6 of its last 6 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 18, 2026, came in 2.44% above the estimate and the stock moved +0.97% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 68.7, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 68.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of IBN
The score, the reasoning behind it, and what could move the price next.
ICICI Bank Ltd. Sponsored (IBN) is trending up. The price of $29.99 sits 3.49% above its 50-day average of $28.98 and 4.95% above its 200-day average of $28.58. Within its 52-week range it stands at 73%, and it is 5.84% below the 52-week high of $31.85. Its 50-day average is also 1.41% above the 200-day average.
Recent gains sit against a weaker longer record: the price rose 6.54% over the past month, rose 0.77% over the past three months and fell 5.93% over the past year. On momentum, the 14-day RSI reads 68.7, in the bullish zone, below the overbought line, with the MACD line positive. The price rose 1.87% in the last session on volume 41.5% above its average.
Earnings beat ›
The July 18, 2026 report beat the EPS estimate by 2.44%, and the share price rose 0.97% in the first session after it.
Source: Earnings report, July 18, 2026
No risks flagged.
- Two levels deserve attention: the 52-week high at $31.85, which lies above the price, and the 50-day SMA at $28.98, which lies below it.
- A 14-day RSI of 68.7 sits in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would mark stretched momentum.
- In the first session after the July 18, 2026 report, IBN's share price rose 0.97%. Over its last 6 reports, the company beat estimates in 6 of the last 6.
IBN trades above its 50-day and 200-day moving averages ($28.98 and $28.58), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 50-day SMA at $28.98.
The next level overhead is the 52-week high of $31.85. With RSI in the bullish band, momentum supports the current direction, though the reading is close to the overbought threshold.
Technical indicators
Momentum and trend for IBN, from its daily closes.
As of October 17, 2026, with IBN at $29.99, its 14-day RSI is 68.7 (showing bullish momentum without being overbought), its 50-day simple moving average is $28.98 and its 200-day is $28.58.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What IBN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, IBN's 1-year correlation of daily returns is +0.32 with S&P 500 (SPY), +0.24 with Nasdaq 100 (QQQ), +0.13 with Bitcoin (BTC) and +0.08 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
4 of 4 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $36.50 is 21.7% above the price.More buy ratings than three months ago ›
4 of 4 rate it a buy now, against 4 of 4 three months ago.
IBN Wall Street View
12-month price targets
The price, $29.99, sits below every analyst's target.
Ratings
As of October 17, 2026, 4 Wall Street analysts cover IBN: 4 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $35.30 to $38.00, with a median of $36.50, 21.7% above the price of $29.99.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
IBN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from IBN's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much IBN tends to move, against the market and on its own.
The long record
IBN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.42% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 49.4%, from February 2020 to May 2020, regained by February 2021.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $45,598, against $42,055 in the S&P 500 (SPY).
IBN Drawdowns & Recovery
As of October 17, 2026, IBN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -49.4% (February 2020 to May 2020); it regained that peak by February 2021, 9 months after the low, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into IBN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: IBN beat the S&P 500 over this period: $45,598 against $42,055.
A $10,000 investment in IBN in October 2016 would be worth about $45,598 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to IBN, and which have not.
Strongest month, October: an average of +4.33%, up in 8 of 9 years.
Weakest month, March: an average of -4.85%, up in 5 of 10 years.
This month, October: has averaged +4.33%, up in 8 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, IBN's strongest calendar month has been October (average +4.33%, up in 8 of 9 years) and its weakest March (average -4.85%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in IBN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IBN today could grow to about $24,597 by 2036 in the base case, with a 90th-percentile outcome near $87,084 and a 10th-percentile outcome around $6,947. Projections are statistical simulations, not guarantees.
IBN Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $42.99 for IBN by 2030 in the base case, from $29.99 today (1.4x over 4 years). The 10th-percentile path ends near $19.32. These are outcomes of a Monte Carlo simulation run on IBN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $22.00 | $32.81 | $48.94 | |
| 2028 | $20.40 | $35.90 | $63.20 | |
| 2029 | $19.66 | $39.29 | $78.52 | |
| 2030 | $19.32 | $42.99 | $95.63 | |
| 2031 | $19.24 | $47.03 | $115 |
Method: a lognormal simulation of IBN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Questions people ask
Answered from the figures on this page, as of October 17, 2026.